Stockreport

X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]

X4 Pharmaceuticals, Inc.  (XFOR) 
Last x4 pharmaceuticals, inc. earnings: 3/12 07:30 am Check Earnings Report
PDF Positive interim data from Phase 2 trial of mavorixafor in chronic neutropenia; full trial results expected in November 2024 Initiated global, pivotal Phase 3 trial o [Read more]